Dong Chune Christopher Chung - 21 Jul 2022 Form 4 Insider Report for NATUS MEDICAL INC

Role
Chief Medical Officer
Signature
/s/ DOUGLAS BALOG by POWER OF ATTORNEY
Issuer symbol
N/A
Transactions as of
21 Jul 2022
Net transactions value
-$3,246,344
Form type
4
Filing time
21 Jul 2022, 17:06:03 UTC
Previous filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTUS Common Stock, $0.001 par value per share Award $0 +35,056 +73% $0.000000 83,374 21 Jul 2022 Direct F1
transaction NTUS Common Stock, $0.001 par value per share Disposed to Issuer $2,793,029 -83,374 -100% $33.50 0 21 Jul 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTUS Nonqualified Stock Option Disposed to Issuer $453,315 -35,360 -100% $12.82 0 21 Jul 2022 Common Stock 35,360 $20.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dong Chune Christopher Chung is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock subject to performance-based stock unit awards that vested and were settled as a result of the merger ("Merger") pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc. ("Parent"), Prince Mergerco Inc, and Issuer ("Merger Agreement").
F2 Disposed of as a result of the Merger.
F3 Each share of Common Stock, including shares underlying equity awards, was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to applicable tax withholding.
F4 This option, which provided for vesting in four equal annual installments beginning November 13, 2021, was (to the extent not previously exercised) cancelled in the Merger pursuant to the Merger Agreement in exchange for a cash payment, per option share, representing the difference between the per share exercise price of the option and the per share cash consideration provided in the Merger Agreement ($33.50), subject to applicable tax withholding.